Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Fosun Foundation Donates COVID-19 Therapy Azvudine to Rural China
January 25, 2025
Policy / Regulatory
NMPA Approves Expanded Production for COVID-19 Symptom Treatments
January 25, 2025
Company
Drug
Roche’s Glofitamab and Dizal’s Sunvozertinib Enter Priority Review
January 25, 2025
Company
Deals
Yinjia Biosciences Raises RMB 100 Million in Series A Financing Round
January 25, 2025
Policy / Regulatory
China Optimizes Medical Insurance Policies for COVID-19 Treatment
January 25, 2025
Company
Deals
China Resources Biopharmaceutical Secures RMB 600 Million in Series B Funding
January 25, 2025
Company
Drug
Adagene’s ADG126 Shows Promise in Combination with Anti-PD-1 Therapy
January 25, 2025
Company
Pfizer CEO Denies Licensing Paxlovid to Chinese Generics Firms
January 25, 2025
Company
Legend Biotech Receives Nasdaq Notice Regarding Listing Compliance
January 25, 2025
Company
Drug
Jiangxi Jemincare’s JMKX003142 Gets FDA Nod for Clinical Study
January 26, 2025
Company
Drug
Pfizer’s Paxlovid Excluded from China’s NRDL Amid Price Dispute
January 25, 2025
Policy / Regulatory
China Strengthens COVID-19 Prevention and Control in Rural Areas
January 25, 2025
1
2
…
1,053
1,054
1,055
1,056
1,057
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?